AzTrials
AzTrials

Acute Respiratory FailureCHESTSPANNCT06357780

Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive ventilationPatients

A study testing Conventional in people with Acute Respiratory Failure and Acute Respiratory Distress Syndrome, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The study is a multicentric prospective randomised cross-over study. It evaluates the compatibility of patients with the device without altering the routine treatment applied. During this evaluation, either the clinician-adjusted values on the device or the standard pre-set values are used to obtain hourly and… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Conventional
Could I receive a placebo?
No, everyone receives an active treatment
How many people
38 participants
Where
1 siteTurkey (Türkiye)
Study dates
8 Apr 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients older than 18 years of age
  • Hospitalized at the ICU or emergency department with the intention of treatment with Noninvasive ventilation at least for the upcoming 2 hours with spontaneous breathing activity
  • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation

Who cannot join

  • Formalized ethical decision to withhold or withdraw life support
  • Patient included in another interventional research study under consent
  • Patient already enrolled in the present study in a previous episode of respiratory failure
  • Pregnant woman
  • Patients deemed at high risk for the need of transportation from an intensive care unit or emergency department to another ward, diagnostic unit or any other hospital
  • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine > 1 mg/h
Show all 9Show fewer
  • Not being able to obtain reference waveforms due to technical or medical problems
  • Vulnerable population
  • Increase or decrease of ventilatory support either in pressures, fraction of inspired oxygen or mode of ventilation during study period

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Ramazan Guven, Associate professor contact

05324935995

drramazanguven@gmail.com

Tuba Dogan, MD contact

dr.tubadogan@hotmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Dr.Suat Seren Chest Diseasees Hospital

    Izmir, 35230

    Cenk Kirakli, professor

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive Ventilation Patients (CHEST-SPAN) - a Randomized Cross-over Trial

The study is a multicentric prospective randomised cross-over study. It evaluates the compatibility of patients with the device without altering the routine treatment applied. During this evaluation, either the clinician-adjusted values on the device or the standard pre-set values are used to obtain hourly and 30-minute PVA (Patient Ventilator Asynchrony) recordings. These recordings will be analysed offline to identify the settings used and to compare the hourly and 30-minute PVA (Patient Ventilator Asynchrony) values when synchronisation is automatically set. The relationships and differences between these values will be analysed. For this purpose, the IntelliSync+ option, already available on the device, will be used. This software continuously analyses waveform signals at least a hundred times per second. This allows for the immediate detection of patient efforts and the initiation of inspiration and expiration in real time, thereby replacing traditional trigger settings for inspiration and expiration. If the patient is already synchronised with this option, it will then be possible to switch to traditional synchronisation settings for comparison. Statistical analyses will be conducted using SPSS 24.0, JASP (Just Another Statistical Programme), Jamovi ( fork of JASP), or R software. Initially, all numerical and categorical data will be evaluated using descriptive statistical methods. The distributions of numerical variables will be examined using visual (histograms and probability plots) and analytical methods (Kolmogorov-Smirnov/Shapiro-Wilk tests). Mean/SD (standard deviation) or median/interquartile range (IQR) will be used as measures of distribution. For comparing numerical data that follows a normal distribution, the Student-t test will be used, and for non-normally distributed data, the Mann-Whitney U or Wilcoxon signed-rank tests will be employed. PVA (Patient Ventilator Asynchrony) values will be statistically compared. For the analysis of categorical data, the Chi-Square test will be applied. Bayesian analysis may also be used as necessary during the writing of the study. The results obtained will be interpreted and reported by the researchers. Results with a "p" value below 0.05 will be considered statistically significant.

Being tested
close-loop synchronization controller with spontaneous mode, Conventional
Keywords
Acute respiratory failure (ARF), noninvasive ventilation, Closed-loop, synchronization, patient ventilator asynchrony
Medical subject headings
Respiratory Distress Syndrome, Patient-Ventilator Asynchrony

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • close-loop synchronization controller with spontaneous modeOther

    30 minutes period where the pressure support of spontaneous effort will be automatically titrated based on pressure and flow waveform analysis obtained from the patient during NIV mode.

  • ConventionalOther

    30 minutes period where the synchronization of pressure support of patient effort during NIV mode will be manually set.

Study groups in NCT06357780
Study groupRoleWhat they receive
Close-loop synchronization controllerExperimental30 minutes period where the pressure support of spontaneous effort will be automatically titrated based on pressure and flow waveform analysis obtained from the patient during NIV mode.
Receives: Other: close-loop synchronization controller with spontaneous mode
ConventionalActive comparator30 minutes period where the synchronization of pressure support of patient effort during NIV mode will be manually set.
Receives: Other: Conventional

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Asynchrony Index

    [(detectable asynchronies )/(total number of breaths + ineffective efforts)]x100

    Measured: 30 minutes

Secondary outcomes (3)
  1. Major Asynchrony index

    [(major asynchronies)/(total number of breaths + ineffective efforts)]x100

    Measured: 30 minutes

  2. Minor Asynchrony index

    [(minor asynchronies)/(total number of breaths + ineffective efforts)]x100

    Measured: 30 minutes

  3. Dyspnea Scale

    Patient subjective dyspnea scale

    Measured: 30 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2024
  2. Study start8 Apr 2024
  3. Primary completion30 Aug 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Participant
Enrolment
38 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06357780
Sponsor's protocol ID
240396837
Acronym
CHESTSPAN
Status last verified
Mar 2025
First submitted
5 Apr 2024
Last updated
26 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Thille AW, Rodriguez P, Cabello B, Lellouche F, Brochard L. Patient-ventilator asynchrony during assisted mechanical ventilation. Intensive Care Med. 2006 Oct;32(10):1515-22. doi: 10.1007/s00134-006-0301-8. Epub 2006 Aug 1.

    PubMed 16896854
  • Longhini F, Bruni A, Garofalo E, Tutino S, Vetrugno L, Navalesi P, De Robertis E, Cammarota G. Monitoring the patient-ventilator asynchrony during non-invasive ventilation. Front Med (Lausanne). 2023 Jan 19;9:1119924. doi: 10.3389/fmed.2022.1119924. eCollection 2022.

    PubMed 36743668
  • Itagaki T, Akimoto Y, Nakano Y, Ueno Y, Ishihara M, Tane N, Tsunano Y, Oto J. Relationships between double cycling and inspiratory effort with diaphragm thickness during the early phase of mechanical ventilation: A prospective observational study. PLoS One. 2022 Aug 17;17(8):e0273173. doi: 10.1371/journal.pone.0273173. eCollection 2022.

    PubMed 35976965
  • Xu Z, Sheng D, Jiao K, Zhang C, Hao J, Ma D. Factors affecting abnormal triggering with non-invasive ventilators: A before-and-after study. Clin Respir J. 2022 Jun;16(6):450-459. doi: 10.1111/crj.13497. Epub 2022 May 31.

    PubMed 35642081
  • Mojoli F, Pozzi M, Orlando A, Bianchi IM, Arisi E, Iotti GA, Braschi A, Brochard L. Timing of inspiratory muscle activity detected from airway pressure and flow during pressure support ventilation: the waveform method. Crit Care. 2022 Jan 30;26(1):32. doi: 10.1186/s13054-022-03895-4.

    PubMed 35094707
  • Guven R, Kirakli C, Revely JP, Colak M, Dogan T, Novotni D, Aurucci V, Altug E, Yildirim S, Sunecli O, Agin H, Ceylan G. Closed-loop versus conventional synchronization in spontaneously breathing adult patients- a randomized controlled study. J Crit Care. 2026 Aug 14;97:155705. doi: 10.1016/j.jcrc.2026.155705. Online ahead of print.

    PubMed 42600333

Questions about this trial

What is this clinical trial studying?

A study testing Conventional in people with Acute Respiratory Failure and Acute Respiratory Distress Syndrome, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ramazan Guven, Associate professor (05324935995, drramazanguven@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Asynchrony Index (time frame: 30 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06357780, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in